Everolimus combination improved progression-free survival in neuroendocrine tumorsOncology Nurse AdvisorProgression-free survival improved in patients with advanced neuroendocrine tumors associated with carcinoid syndrome when the patients used everoli…
Omaha teen takes lip balm idea from concept to completionOmaha World-HeraldThere were lip balms with medications in them, but no skin balms that contained medications, such as hydrocortisone, or any that were specifically aimed at dry, cracked skin on …
MedIndiaStudy: Women With Advanced Breast Cancer Can Double SurvivalMiddle East North Africa Financial Network(MENAFN Press) A new study has revealed that women suffering from breast cancer can survive for twice as long without disease progression, or …
Weaning transplant recipients from their immunosuppressive drugsEurekAlert (press release)Transplant surgeons live in the hope that one day they will be able to wean at least some of their patients off the immunosuppressive drugs that must be taken to …
Toxicity Without Benefit With Paclitaxel Plus EverolimusMedscapeDecember 12, 2011 (San Antonio, Texas) — It seemed like a good idea at the time, but including everolimus (Afinitor, Novartis) in a neoadjuvant chemotherapy regimen with paclitaxel (Taxo…
Breast cancer victims 'can double survival time'Trade ArabiaWomen suffering from breast cancer can survive for twice as long without disease progression using the Novartis-made drug Afinitor (everolimus) in conjunction with hormonal therapy, sa…
PR Web (press release)New Pomelo Resources Published at Pomology.orgPR Web (press release)Other resources provide scientific information on pomelo including a paper on inhibitory effects of pomelo on the metabolism of tacrolimus and the activities of C…
SABCS: Everolimus No Boon for Refractory HER2-Negative DiseaseMedPage TodayExplain that the addition of everolimus (Afinitor) to paclitaxel (Taxol) for women with HER2-negative breast cancer who do not respond to initial chemotherapy won't improve …
Adding Gemcitabine to First-Line Treatment Regimen Increases Efficacy in …Monthly Prescribing ReferenceSAN DIEGO, CA—A first-line regimen that incorporated gemcitabine with rituximab, cyclophosphamide, vincristine, and prednisolone (R-GCVP) for the…
USA TodaySteroids may boost survival for very preemie babiesUSA Today"If it looks like you are going to deliver even as early as 23 weeks, you should have a discussion with your doctor and be offered corticosteroids." For more information abo…